Literature DB >> 12296850

Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis.

A Verbon1, J C Leemans, S Weijer, S Florquin, T Van Der Poll.   

Abstract

A T helper (Th) 1 immune response is important for host defense against tuberculosis. The multidrug resistance protein (Mrp) 1 is constitutively present at low levels on Th2 lymphocytes, and is expressed on Th1 lymphocytes upon activation. To determine the role of Mrp1 in the pathogenesis of tuberculosis, Mrp1 deficient (-/-) and normal wild type mice were intranasally infected with Mycobacterium tuberculosis. At 2 weeks after infection, Mrp1(-/-) mice had reduced levels of the Th1 cytokine interferon-gamma and an impaired granuloma formation in their lungs. At 5 weeks postinfection, M. tuberculosis outgrowth was enhanced in lungs and livers of Mrp1(-/-) mice. A more prolonged observation of these mice, up to 4 months, revealed no differences in survival or mycobacterial outgrowth. These data suggest that Mrp1 plays an early but dispensable role in the protective immune response to pulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296850      PMCID: PMC1906484          DOI: 10.1046/j.1365-2249.2002.01952.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

Review 1.  Role of CD8 T cells in mycobacterial infections.

Authors:  S M Smith; H M Dockrell
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

2.  The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells.

Authors:  S Prechtl; M Roellinghoff; R Scheper; S P Cole; R G Deeley; M Lohoff
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

3.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.

Authors:  I M Orme; A D Roberts; J P Griffin; J S Abrams
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

5.  Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice.

Authors:  J C Leemans; N P Juffermans; S Florquin; N van Rooijen; M J Vervoordeldonk; A Verbon; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis.

Authors:  N P Juffermans; S Florquin; L Camoglio; A Verbon; A H Kolk; P Speelman; S J van Deventer; T van Der Poll
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

7.  A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo.

Authors:  M Lohoff; S Prechtl; F Sommer; M Roellinghoff; E Schmitt; G Gradehandt; P Rohwer; B D Stride; S P Cole; R G Deeley
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

Review 8.  A family of drug transporters: the multidrug resistance-associated proteins.

Authors:  P Borst; R Evers; M Kool; J Wijnholds
Journal:  J Natl Cancer Inst       Date:  2000-08-16       Impact factor: 13.506

9.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  6 in total

Review 1.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 2.  ATP-binding cassette (ABC) transporters in normal and pathological lung.

Authors:  Margaretha van der Deen; Elisabeth G E de Vries; Wim Timens; Rik J Scheper; Hetty Timmer-Bosscha; Dirkje S Postma
Journal:  Respir Res       Date:  2005-06-20

3.  Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae.

Authors:  Shilpi Chandra; James Gray; William B Kiosses; Archana Khurana; Kaori Hitomi; Catherine M Crosby; Ashu Chawla; Zheng Fu; Meng Zhao; Natacha Veerapen; Stewart K Richardson; Steven A Porcelli; Gurdyal Besra; Amy R Howell; Sonia Sharma; Bjoern Peters; Mitchell Kronenberg
Journal:  Nat Commun       Date:  2018-10-15       Impact factor: 14.919

4.  Conserved amino acids in the region connecting membrane spanning domain 1 to nucleotide binding domain 1 are essential for expression of the MRP1 (ABCC1) transporter.

Authors:  Emma E Smith; Gwenaëlle Conseil; Susan P C Cole
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

5.  Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway.

Authors:  Fulin Tao; Yuanyuan Zhou; Mengwen Wang; Chongyang Wang; Wentao Zhu; Zhili Han; Nianxia Sun; Dianlei Wang
Journal:  Korean J Physiol Pharmacol       Date:  2022-03-01       Impact factor: 2.016

6.  Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice.

Authors:  Margaretha van der Deen; Wim Timens; Hetty Timmer-Bosscha; Barry W van der Strate; Rik J Scheper; Dirkje S Postma; Elisabeth G de Vries; Huib A Kerstjens
Journal:  Respir Res       Date:  2007-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.